MyOme - Patients

Take control of your health

Receive genomic-informed risk assessment and diagnostic answers to make informed health choices, supported by resources from the moment your test is ordered.

Cancer

Over 2 million new cancer diagnoses were estimated in 2024 for the first time ever in the Untied States.¹

That's roughly 5,500 per day.¹

Heart Disease

Heart disease and stroke will affect at least 60% of adults in the United States by 2050.²

This will triple current associated disease treatment costs to nearly 1.8 Trillion.²

Diabetes

From 2020 to 2050, the expected diabetes rate is projected to climb from 16.3% to 26.8%.³

Currently, 38% of the U.S. adult population have prediabetes.³

American Cancer Society 2024 Facts & Figures https://www.cancer.org/research/acs-research-news/facts-and-figures-2024.htm
American Heart Association Heart Disease & Stroke Could Affect at Least 60 percent of adults in us by 2050
CDC National Diabetes Statistics Report https://www.cdc.gov/diabetes/php/data-research/index.html

Learning from your genome

MyOme's state of the art technology analyzes the entire genome, offering a comprehensive view of your health risks. One test provides data for various tests, helping inform lifestyle, medication choices, family planning, and personalized screening and treatment decisions with your provider.

Proactive Health tests

Genetic screening to help identify personal health risks for conditions such as heart disease and breast cancer, and guide prevention and treatment decisions.

Proactive Health Tests

Diagnostic Tests

Answers for those who may have a disease with genetic causes, to help identify their condition and create a path forward.

Diagnostic Tests

I wish I had known this before my heart attack. I would have saved some of my heart from infarcting and I would have been able to possibly avoid the situation altogether [...] Because it allows a normal, healthy person to actually change behavior before they actually have the pathology take place.

Protections for patient privacy

MyOme is committed to patient data privacy. We never share or sell genetic data without consent, encrypt all data, and regularly update systems to meet the latest security standards.

Privacy and Security

Ordering a test

We offer insurance coverage for diagnostic tests, and flexible payment options including FSA/HSA eligibility for screening tests. Talk to your healthcare provider about ordering a MyOme test.